Transition risks of net zero

The transition to net zero is well underway, but it won’t be a smooth path and getting there will pose significant risks for investors. These are the conclusions of a new report by Pictet Asset Management and the Institute of International Finance. It will require higher levels of borrowing by the companies they invest in; the risk of transition-related “greenflation”, along with increases in unemployment; and the possibility of creating asset-price bubbles as a vast amount of capital chases a relatively constrained supply of assets.

To avoid these pitfalls and others, investors must take a measured approach to assessing opportunities as they arise, including assessing the extent to which markets have already priced-in the “greenness” of companies, and what implications that has for alpha generation. And that requires deep research and confidence in available data – which in some cases continues to be patchy.

Pictet Asset Management senior investment manager Yuko Takano, managing investment director, sustainable investments at CalPERS Peter Cashion and Institute of International Finance director Emre Tiftik discuss the opportunities and risks investors need to understand to maximise returns as the energy transition progresses.

In conversation with Top1000funds.com editor Amanda White, they discuss how it’s possible to generate outperformance by investing in climate solutions; and how investors should think about the associated risk and alpha opportunities.

Sponsored Content

Leave a Comment

New Jersey’s $85 billion fund stockpiles cash, eyes PE secondaries

New Jersey’s $85 billion fund stockpiles cash, eyes PE secondaries

An underweight position across private markets, predicated on a view that geopolitics and inflation mean interest rates are not coming down any time soon, has positioned the New Jersey Division of Investment with plenty of dry powder and a cash position four times the policy allocation. It is now readying for opportunities in private equity secondaries and with emerging managers. Chief investment officer Shoaib Khan spoke to Top1000funds.com.

Sort content by

Denmark’s Sampension favours CLOs

Sampension, the DKK325.6 billion labour-market Danish pension fund has found a rich seam investing in AAA-rated CLOs where it earns a pick-up from traditional fixed income in loans with low default rates. The head of credit Anders Tauber Lassen says the fund feels "quite comfortable taking this type of risk".

Looking less at the scoreboard

Traditional performance monitoring reports do more harm than good, argues Phil Edwards, who suggests a more effective monitoring framework shifts the focus away from performance numbers and towards the fundamental characteristics of the stocks held in the portfolio, perhaps borrowing some elements from private markets.

NZ Super reviews reference portfolio

The NZ$43 billion ($27 billion) New Zealand Super Fund is undergoing its five-yearly review of its reference portfolio, an innovative and unique asset allocation reference point that allows the fund to benchmark the performance of its actual portfolio and any value added through active management.

Bridgewater and UTIMCO talk China

The $41 billion University of Texas Investment Management has been investing in China since 2007 and its CIO, Britt Harris says it “must be taken seriously”. Presenting at the endowment's board meeting, co-CIO of Bridgewater, Bob Prince, agreed, saying “China is too big to avoid”.

OTPP bucks trend, keeps buying bonds

Just as some of the world’s largest pensions funds sell down their fixed income holdings in favour of equities and private assets, Ontario Teachers’ Pension Plan has been buying more in 2019 as it seeks to rebalance the portfolio in the event of an economic downturn.

Healthcare’s multiple opportunities

William Haseltine had a long career at Harvard Medical School, educating a generation of doctors, and designing the strategy to develop the first treatment for HIV/AIDS. He addressed the Fiduciary Investors Symposium about important topics in medicine and health development.

Previous